ProSomnus (ProSomnus) Gross Margin % : 47.27% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ProSomnus Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. ProSomnus's Gross Profit for the three months ended in Dec. 2023 was $3.71 Mil. ProSomnus's Revenue for the three months ended in Dec. 2023 was $7.84 Mil. Therefore, ProSomnus's Gross Margin % for the quarter that ended in Dec. 2023 was 47.27%.

The historical rank and industry rank for ProSomnus's Gross Margin % or its related term are showing as below:

OSAPQ' s Gross Margin % Range Over the Past 10 Years
Min: 49.72 Med: 51.31 Max: 52.94
Current: 50.67

During the past 4 years, the highest Gross Margin % of ProSomnus was 52.94%. The lowest was 49.72%. And the median was 51.31%.

OSAPQ's Gross Margin % is ranked worse than
54.02% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.135 vs OSAPQ: 50.67

ProSomnus had a gross margin of 47.27% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for ProSomnus was 0.00% per year.

ProSomnus Gross Margin % Historical Data

The historical data trend for ProSomnus's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProSomnus Gross Margin % Chart

ProSomnus Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Gross Margin %

49.72

51.94

52.94

50.67

ProSomnus Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial							53.61	52.55	54.27	49.37	47.27

Competitive Comparison of ProSomnus's Gross Margin %

For the Medical Devices subindustry, ProSomnus's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProSomnus's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ProSomnus's Gross Margin % falls into.

ProSomnus Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

ProSomnus's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	14	/	27.652
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(27.652 - 13.641)	/	27.652
	=	50.67 %

ProSomnus's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	3.7	/	7.838
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(7.838 - 4.133)	/	7.838
	=	47.27 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

ProSomnus (OTCPK:OSAPQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ProSomnus had a gross margin of 47.27% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

ProSomnus Gross Margin % Related Terms

Thank you for viewing the detailed overview of ProSomnus's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ProSomnus (ProSomnus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5675 Gibraltar Drive, Pleasanton, CA, USA, 94588

Website

https://www.prosomnus.com

ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.

Executives

Sung Kim	officer: Chief Technical Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens	10 percent owner	C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow	officer: Chief Financial Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp	10 percent owner	65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers	director	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak	director, officer: Chief Executive Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy	officer: Chief Growth Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli	director	5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc	10 percent owner	C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp	10 percent owner	505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge	director	7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073